How the Strategy of Breast Reconstruction Changed in Our Hospital after the Allergan Crisis

DOI
  • Kuramoto Yukiko
    Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital
  • Yano Tomoyuki
    Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital
  • Yoshimatsu Hidehiko
    Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital
  • Suesada Nobuko
    Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital
  • Shibata Tomoyoshi
    Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital
  • Karakawa Ryo
    Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital
  • Maeda Erisa
    Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital
  • Miyashita Hiroki
    Department of Plastic and Reconstructive Surgery, Cancer Institute Hospital

Bibliographic Information

Other Title
  • Allergan Crisis を経て当院における乳房再建はどう変わったか

Search this article

Description

<p>Introduction : On July 25th 2019, the FDA announced a recall for Allergan's Biocell silicone breast implants (SBI) and tissue expanders (TE) . After the recall of these products, breast reconstruction using SBI and TE was stopped. We investigated how the strategy for breast reconstruction at our institute changed after this Allergan crisis.</p><p>Methods : One hundred and fifty-eight cases of tissue expander use between January 1st 2019 and July 24th 2019 were included in this study. The reconstruction method, surgery schedule and primary reconstruction plan were investigated.</p><p>Results : There were 87 cases of breast reconstruction with autologous tissue transfer, 36 cases of SBI, 25 cases of TE removal and 11 cases of undecided reconstruction. Approximately 30% of planned SBI reconstruction cases were switched to autologous tissue reconstruction.</p><p>Conclusion : The Allergan crisis increased the number of cases of autologous breast reconstruction. Patients may prefer to choose breast reconstruction with a lower risk of ALCL, and have a negative image of breast reconstruction using artificial materials.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top